Furthermore, HuR can bind PARG mRNA under PARP inhibitor stress, and the inhibition of HuR combined with PARG mRNA helps to improve the effectiveness of PARP inhibitory therapy in pancreatic cancer cells [93]. This evidence concerns the gene ELAVL1 and familial pancreatic carcinoma.